TECH - Bio-Techne Corp -  [ ]

Ticker Details
Bio-Techne Corp
Bio-Techne Corp and is a biotechnology company which develops, manufactures and sells biotechnology reagents, instruments and clinical diagnostic products.
IPO Date: March 1, 1989
Sector: Healthcare
Industry: Life Sciences Tools and Services
Market Cap: $7.55B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.47 | 1.17%
Avg Daily Range (30 D): $1.59 | 3.01%
Avg Daily Range (90 D): $1.27 | 2.27%
Institutional Daily Volume
Avg Daily Volume: .41M
Avg Daily Volume (30 D): 2.49M
Avg Daily Volume (90 D): 2.19M
Trade Size
Avg Trade Size (Sh.): 78
Avg Trade Size (Sh.) (30 D): 64
Avg Trade Size (Sh.) (90 D): 61
Institutional Trades
Total Institutional Trades: 8,269
Avg Institutional Trade: $4.78M
Avg Institutional Trade (30 D): $3.47M
Avg Institutional Trade (90 D): $4.15M
Avg Institutional Trade Volume: .27M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $9.09M
Avg Closing Trade (30 D): $16.92M
Avg Closing Trade (90 D): $19.31M
Avg Closing Volume: 399.4K
 
News
May 6, 2026 @ 5:35 PM
S&P 500, Nasdaq 100 Smash Records As AMD Jumps 16%...
Source: Piero Cingari
Mar 20, 2026 @ 11:00 AM
ELISpot & FluoroSpot Assay Market Report 2026-2031...
Source: Researchandmarkets.Com
Feb 4, 2026 @ 11:30 AM
Bio-Techne Declares Dividend
Source: Prnewswire
Jan 21, 2026 @ 9:42 AM
Middle East Exosomes Market Research Report 2025-2...
Source: Researchandmarkets.Com
Nov 5, 2025 @ 11:30 AM
BIO-TECHNE DECLARES DIVIDEND
Source: Prnewswire
Financials
  TTM Q3 2026 Q2 2026
Basic EPS $.71 $.33 $.24
Diluted EPS $.7 $.32 $.24
Revenue $1.21B $311.42M $295.88M
Gross Profit $786.49M $208.29M $191.28M
Net Income / Loss $109.56M $51.05M $38.01M
Operating Income / Loss $153.75M $75.5M $54.46M
Cost of Revenue $424.32M $103.13M $104.6M
Net Cash Flow $57.77M $38.13M $27.5M
PE Ratio    
Splits
Nov 30, 2022 4:1
Nov 10, 2022 4:1
Dec 04, 2000 2:1